QA: Biospecifics Technologies CORP in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000875622_2015_Biospecifics_Technologies_CORP.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000875622, Biospecifics Technologies CORP

  xvar xval
0 AssetsCurrent 25,148,810
1 IntangibleAssetsNetIncludingGoodwill 295,030
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 5,582,984
4 LiabilitiesCurrent 671,212
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,754,437
9 ResearchAndDevelopmentExpense 1,184,790
10 remainder_Expenses 2,438,995
11 remainder_Revenues 14,090,382
12 remainder_NetIncome 31,393
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 31,026,824
1 Liabilities 671,212
2 Expenses 9,378,222
3 Revenues 14,090,382
4 StockholdersEquity 30,355,612
5 NetIncome 4,743,553
6 ComprehensiveNetIncome 4,743,553
7 BaseVar 27,599,016
8 EconomicCapitalRatiobeforeLimitedLiability 4.47
9 EconomicCapitalRatio 4.76

Edgar->Model Mapping

Feature Distribution

Change over Time